Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Olink Holding Ab [Publ] ADR
(NQ:
OLK
)
24.03
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Olink Holding Ab [Publ] ADR
< Previous
1
2
3
4
Next >
Landmark studies utilizing Olink® Explore technology signal a new era for population-scale proteogenomics
October 05, 2023
From
Olink Proteomics AB
Via
GlobeNewswire
Announcing the Olink® Target 48 Mouse Cytokine Panel – the next generation in immunoassays designed to accelerate translational research.
September 19, 2023
Discover more with less. Unmatched specificity and sensitivity deliver translational insights from 1µl of sample.
From
Olink Proteomics AB
Via
GlobeNewswire
Eurofins Genomics adopts Olink® technology to advance proteomics research and accelerate precision medicine programs
September 12, 2023
From
Olink Proteomics AB
Via
GlobeNewswire
Earnings Preview For Olink Holding
August 08, 2023
Via
Benzinga
Olink Holding: Q1 Earnings Insights
May 11, 2023
Via
Benzinga
Analyst Ratings for Olink Holding
February 22, 2023
Via
Benzinga
Olink Holding's Earnings Outlook
February 20, 2023
Via
Benzinga
Olink to participate in September investor events
August 29, 2023
From
Olink Proteomics AB
Via
GlobeNewswire
Olink reports second quarter 2023 financial results
August 09, 2023
From
Olink Proteomics AB
Via
GlobeNewswire
Baylor College of Medicine Human Genome Sequencing Center adopts Olink® Explore HT proteomics platform
August 08, 2023
From
Olink Proteomics AB
Via
GlobeNewswire
Olink to report second quarter 2023 financial results on August 9, 2023, and to participate in the Canaccord Genuity 43rd Annual Growth Conference
July 13, 2023
From
Olink Proteomics AB
Via
GlobeNewswire
Why Olink Shares Are Trading Lower Today?
January 19, 2023
Olink (NASDAQ: OLK) shares are trading lower after the company announced pricing of a public offering of American Depositary Shares.
Via
Benzinga
Announcing Olink® Explore HT – A New Era in Proteomics
July 12, 2023
A High-throughput Protein Biomarker Discovery Platform with Proven Specificity at Any Scale
From
Olink Proteomics AB
Via
GlobeNewswire
Revealing the secrets of the human proteome with Olink® Insight: Exploring findings from one of the world's largest health studies
June 28, 2023
From
Olink Proteomics AB
Via
GlobeNewswire
Olink to participate in June investor events
May 25, 2023
From
Olink Proteomics AB
Via
GlobeNewswire
Olink reports first quarter 2023 financial results
May 11, 2023
From
Olink Proteomics AB
Via
GlobeNewswire
Report from the Annual General Meeting of Olink Holding AB (publ) on 17 April 2023
April 17, 2023
From
Olink Proteomics AB
Via
GlobeNewswire
Olink to report first quarter 2023 financial results on May 11, 2023
April 13, 2023
From
Olink Proteomics AB
Via
GlobeNewswire
Swedish Olink technology enables further development of South African research and innovation
March 29, 2023
From
Olink Proteomics AB
Via
GlobeNewswire
Olink publishes 2022 annual report
March 27, 2023
From
Olink Proteomics AB
Via
GlobeNewswire
Bruno Rossi joins Olink as Chief Commercial Officer
March 21, 2023
From
Olink Proteomics AB
Via
GlobeNewswire
Notice to attend the Annual General Meeting of Olink Holding AB (publ)
March 15, 2023
From
Olink Proteomics AB
Via
GlobeNewswire
NUS Medicine implements Olink technology to accelerate precision medicine through next-generation proteomics
March 06, 2023
From
Olink Proteomics AB
Via
GlobeNewswire
Olink establishes agreement with Regeneron Genetics Center to scale their proteomics efforts, potentially enabling a new era of drug discovery
February 28, 2023
From
Olink Proteomics AB
Via
GlobeNewswire
Olink reports fourth quarter and full year 2022 financial results
February 21, 2023
From
Olink Proteomics AB
Via
GlobeNewswire
The 7 Best Manufacturing Stocks to Buy for 2023
February 06, 2023
These manufacturing stocks to buy provide a great alternative to tech stocks that have been so badly beaten in recent weeks.
Via
InvestorPlace
Why Jupiter Wellness Shares Are Trading Lower By Around 40%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
January 19, 2023
Gainers Genius Group Limited (NYSE: GNS) jumped 87% to $1.00. Genius Group authorized issue of special dividend and appointed Timothy Murphy to lead Illegal Trading Task Force.
Via
Benzinga
Dow Falls 200 Points; Jobless Claims Drop To 4-Month Low
January 19, 2023
U.S. stocks traded lower this morning, with the Dow Jones dropping around 200 points on Thursday.
Via
Benzinga
Why Is NuZee (NUZE) Stock On The Move Today?
January 19, 2023
NuZee (NUZE) stock is on the move Thursday after the company announced a new partnership with single-serve coffee company Malu.
Via
InvestorPlace
Why Is Olink (OLK) Stock Down 17% Today?
January 19, 2023
Olink (OLK) stock is falling on Thursday as investors react to the pricing of a public offering of the proteomics company's shares.
Via
InvestorPlace
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.